More on the News The FDA stumbled upon Jiangsu Shenli when looking into the possibility of China-made plastic syringes leaking, shattering, or having other quality issues. The officials accused Jiangsu Shenli of marketing 29 different sizes and configurations of piston syringes without clearance or approval. Merit Medical is taking action to shift from Jiangsu Shenli syringes immediately. In the interim, to avoid product shortages, the company is likely to ship products containing the Jiangsu Shenli syringe ...

SOUTH JORDAN, Utah, June 18, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2024, after the close of the stock market on Thursday, August 1, 2024. A live webcast and slide deck can be accessed using this link. A link to both register for the conference call and view the webcast will be made available at merit.com. Contacts: To acc ...

SOUTH JORDAN, Utah, June 18, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2024, after the close of the stock market on Thursday, August 1, 2024. Merit will hold its investor conference call on the same day (Thursday, August 1, 2024) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific). To access t ...

"Hurry up and wait" remains the order of the day for Merit Medical (NASDAQ:MMSI) and its shareholders. While the company has executed pretty well since my last update (some revenue and EBITDA outperformance), and the shares are up about 20%, I suspect there may be some investor frustration that there hasn't been more news to drive a fundamental shift in investment theses – the company has been reasonable (if not conservative) with guidance, hasn't done any big M&A, and has just stuck to its knitting. I rema ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both. Zacks Premium includes access to the Zacks Style Scores as well. The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating ...

A month has gone by since the last earnings report for Merit Medical (MMSI) . Shares have added about 5% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Merit Medical due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers. Merit Medical Q1 Earnings Top Estimates, Margins U ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor. Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? The Za ...

Merit Medical Systems, Inc. (MMSI) recently announced the U.S. commercial release of the basixSKY Inflation Device. The device is available as a standalone solution and in kits with Merit Medical's Angioplasty Packs, configured to offer complementing AccessPLUS, Honor, and PhD hemostasis valves. This month, Merit Medical received the FDA's 510(k) clearance for its Siege Vascular Plug. The company also announced the launch of its Bearing nsPVA Express Prefilled Syringe in the United States and Australia. The ...

Merit Medical Systems, Inc. (MMSI) is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism led by solid first-quarter 2024 performance and its continued spend on research and development (R&D) are expected to contribute further. However, headwinds due to higher consolidation in the healthcare industry and forex volatility persist. Over the past year, this Zacks Rank #3 (Hold) stock has gained 1.4% compared with a 5.5% rise of the industry and 28.6% growth of ...

SOUTH JORDAN, Utah, May 21, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced the US commercial release of the basixSKY Inflation Device. CONTACTS PR/Media Inquiries Sarah Comstock Merit Medical +1-801-432-2864 |sarah.comstock@merit.com INVESTOR INQUIRIES Mike Piccinino, CFA, IRC Westwicke - ICR +1-443-213-0509 |mike.piccinino@westwicke.com TRADEMARKS Unless noted otherwise, trademarks and registered trademarks used in this release ...